Trypanosoma cruzi Defined Antigens in the Serological Evaluation of an Outbreak of Acute Chagas Disease in Brazil (Catolé do Rocha, Paraíba)

Memorias do Instituto Oswaldo Cruz

Volumn 91, Issue 1, 1996, Pages 87-93

  Umezawa, Eufrosina S ^a   Shikanai Yasuda, Maria Aparecida ^a   Gruber, Arthur ^a   Pereira Chioccola, Vera L ^b   Zingales, Bianca ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Acute phase; B13 recombinant protein; Chagas disease; LPPG; Serology; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA; TRYPANOSOMA CRUZI;

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE DISEASE; ADOLESCENT; ADULT; ANIMAL; ARTICLE; BRAZIL; CHAGAS DISEASE; CHILD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; SEROLOGY; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ADOLESCENT; ADULT; ANIMALS; BRAZIL; CHAGAS DISEASE; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SEROLOGIC TESTS; TRYPANOSOMA CRUZI;

EID: 0029689902     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761996000100015     Document Type: Article

References (29)

1. Brener Z, Camargo EP 1982. Perspectives of vaccination in Chagas disease. Pont Acad Sci Scripta Varia 47: 145-168.
2. Camargo MB 1992. An appraisal of Chagas disease serodiagnosis, p. 165-178. In S Wendel, Z Brener, ME Camargo, A Rassi, (eds). Chagas disease (American Trypanosomiasis): its impact on transfusion and clinical medicine. ISBT (International Society of Blood Transfusion), São Paulo.
3. Camargo ME, Amato Neto V 1974. Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection. Rev Inst Med Trop São Paulo 16: 200-202.
4. Colli W 1992. Trypanosoma cruzi: molecular aspects of the host-parasite interaction, p. 259-275. In JE Allende Simposio RELAB (Red Latinoamericana de Ciencias Biologicas) #2, Santiago.
5. Dias JCP 1979. Mecanismos de transmissão, p. 152-174. In Z Brener, Z Andrade, (eds). Trypanosoma cruzi e Doença de Chagas. Guanabara Koogan, Rio de Janeiro.
6. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F 1956. Colorimetric method for determination of sugars and related substances. Anal Chem 28: 350-356.
7. Franco da Silveira J 1992. Trypanosoma cruzi recombinant antigens for serodiagnosis, p. 207-218 In S Wendel, Z Brener, ME Camargo, A Rassi, (eds). Chagas disease (American Trypanosomiasis): its impact on transfusion and clinical medicine. ISBT (International Society of Blood Transfusion), São Paulo.
8. Galvão LMC, Nunes RMB, Cançado JR, Brener B, Krettli AU 1993. Use of lytic antibodies in assessing cure after treatment of Chagas disease: a 10 year follow-up study. Trans R Soc Trop Med Hyg 87: 220-223.
9. Gardner MJ, Altman D 1986. Confidence intervals rather than P values: estimation rather than hypothesis testing. Brit Med J 292: 746-750.
10. Gazzinelli RT, Pereira MES, Romanha A, Gazzinelli GM, Brener Z 1990. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunol 13: 345-356.
11. Golgher DB, Colli W, Souto-Padron T, Zingales B 1993. Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi. Mol Biochem Parasitol 60: 249-264.
12. Gruber A, Zingales B 1993. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas disease. Exp Parasitol 76: 1-12.
13. Hartree EF 1972. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48: 422-427.
14. Krettli AU, Cançado JR, Brener Z 1982. Effect of specific chemotherapy on the levels of lytic antibodies in Chagas disease. Trans R Soc Trop Med Hyg 76: 334-337.
15. Lederkremer RM, Casal OL, Alves MJM, Colli W 1980. Evidence for the presence of D-galactofuranose in the lipopeptidophosphoglycan from Trypanosoma cruzi. FEBS Lett 116: 25-29.
16. Lederkremer RM, Lima C, Ramirez ML, Casal OL 1990. Structural features of the lipopeptidophosphoglycan from Trypanosoma cruzi common with the glycophosphatidylinositol anchors. Eur J Biochem 192: 337-345.
17. Lederekremer RM, Lima C, Ramirez MI, Ferguson MAJ, Homans SW, Thomas-Oates J 1991. Complete structure of the glycan of lipopeptidophosphoglycan from Trypanosoma cruzi epimastigotes. J Biol Chem 266: 23670-23675.
18. Lissaldo AM, Hoshino-Shimizu S, Umezawa ES, Stolf AMS 1994. Alkaline soluble Trypanosoma cruzi epimastigote antigen (ASEA) applied to dot-Elisa. Rev Inst Med trop São Paulo 36: 163-166.
19. Matsumoto TK, Hoshino-Shimizu S, Nakamura PM, Andrade HF, Umezawa ES 1993. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas disease. J Clin Microbiol 31: 1486-1492.
20. Moncayo A 1993. Chagas Disease, p. 67-75. In Tropical Disease Report Progress 1991-92. World Health Organization, Geneva.
21. Pereira VL, Levy AM, Boainain E 1989. Xenodiagnóstico, hemocultura e teste de lise mediada por complemento como critérios de seleção de pacientes chagásicos crônicos para quimioterapia. Rev Inst Med Trop São Paulo 31: 301-307.
22. Primavera KSC, Umezawa ES, Peres BA, Camargo ME, Hoshino-Shimizu S 1990. Chagas disease: IgA, IgM and IgG antibodies to T. cruzi amastigote, trypomastigote and epimastigote antigens in acute and in different chronic forms of the disease. Rev Inst MedTrop São Paulo 32: 172-180.
23. Rassi A, Luquetti AO 1992. Therapy of Chagas Disease, p. 237-247. In S Wendel, Z Brener, ME Camargo, A Rassi, (eds). Chagas disease (American Trypanosomiasis): its impact on transfusion and clinical medicine. ISBT (International Society of Blood Transfusion), São Paulo.
24. Schmuñis GA, Szarfman A, Coarasa L, Guilleron C, Peralta JM 1978. Anti-Trypanosoma cruzi agglutinins in acute human Chagas disease. Am J Trop Med Hyg 29: 170-178.
25. Schnaidman BB, Yoshida N, Gorin PAJ, Travassos LR 1986. Cross-reactive polysaccharides from Trypanosoma cruzi and fungi (specially Dactylium dendroides). J Protozool 33: 186-191.
26. Shikanai-Yasuda MA, Brisola Marcondes C, Guedes LA, Siqueira GS, Barone AA, Dias JCP, Amato Neto V, Tolezano JE, Peres BA, Arruda Jr ER, Lopes MH, Shiroma M, Chapadeiro E 1991. Possible oral transmission of acute Chagas disease in Brazil. Rev Inst Med Trop São Paulo 33: 351-357.
27. Umezawa ES, Stolf AMS, Zingales B 1993. Trypanosoma cruzi: different surface antigens of trypomastigotes are targets of lytic antibodies. Acta Trop 54: 41-53.
28. Wincker P, Britto C, Pereira JB, Cardoso MA, Oelemann W, Morel CM 1994. Use of simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am J Trop Med Hyg 51: 771-777.
29. Zingales B, Golgher D, Marmorato PG, Souto RP, Gruber A 1993. Molecular approaches to diagnosis of Chagas disease: use of defined antigens and a target ribosomal RNA sequence. Biol Res 26: 89-100.